// App-Quantinova.ai

THU0212 : FIRST LINE TREATMENT WITH CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS: A MULTINATIONAL POPULATION-BASED COHORT FROM 14 REAL WORLD HEALTHCARE DATABASES AND 9 COUNTRIES - REALITY VERSUS GUIDELINES

Researchers

Presenter

  • A. G. Sena

Principal Investigators

  • N. Hughes

  • W. Fakhouri

  • A. Hottgenroth

  • R. Kolde

  • S. Reisberg

  • C. O. Torre

  • T. Duarte-Salles

  • Y. Daz

  • J. F. Golib-Dzib

  • E. S. Brouwer

  • E. Burn

  • J. Lane

  • D. Vizcaya

  • S. Bruce Wirta

  • M. De Wilde

  • K. Verhamme

  • P. Rijnbeek

  • E. Theander

  • K. Chatzidionysiou

  • D. Prieto-Alhambra

  • P. Ryan

Medical Centers

  • Janssen Research and Development, Titusville, New Jersey, United States of America

  • Sanofi Aventis Group, Chilly-Mazarin, France

  • Janssen Europe, Middle East and Africa, Beeres, Belgium

  • Eli Lilly and Company, Lilly UK, Erl Wood Manor, Windlesham, Surrey, United Kingdom,

  • Lilly Deutschland GmbH, Bad Homburg, Germany

  • Institute of Computer Science of University of Tartu, Tartu, Estonia

  • Institute of Computer Science of University of Tartu, Tartu, Estonia

  • RWD Oncology Solutions, IQVIA, London, United Kingdom

  • Fundació Inst. Univ.ri per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain

  • Real World Evidence Market Access Department Janssen-Cilag, Madrid, Spain

  • Janssen Europe, Middle East and Africa, New Jersey, United States of America

  • Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

  • Epidemiology, Bayer, Barcelona, Spain

  • Intern, New Jersey, United States of America

  • Department of Medical Informatics and Radiology, Erasmus MC, Rotterdam, Netherlands,

  • Dep of Medicine, Solna, Rheum Unit, Karolinska Institutet, Stockholm, Sweden

  • University of Oxford, Centre for Rehabilitation Research, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), Oxford, United Kingdom

  • Observational Health Data Sciences and Informatics, New York, United States of America

Locations

  • United States

  • France

  • Belgium

  • United Kingdom

  • Germany

  • Estonia

  • Spain

  • Netherlands

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • HWA-486

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved